160 related articles for article (PubMed ID: 30836453)
21. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
[TBL] [Abstract][Full Text] [Related]
22. Salmeterol undergoes enantioselective bronchopulmonary distribution with receptor localisation a likely determinant of duration of action.
Jacobson GA; Raidal S; Robson K; Narkowicz CK; Nichols DS; Walters EH
J Pharm Biomed Anal; 2018 May; 154():102-107. PubMed ID: 29544104
[TBL] [Abstract][Full Text] [Related]
23. Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism.
McCormick C; Alexandre L; Thompson J; Mutungi G
J Appl Physiol (1985); 2010 Dec; 109(6):1716-27. PubMed ID: 20864554
[TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
Darken P; DePetrillo P; Reisner C; St Rose E; Dorinsky P
Pulm Pharmacol Ther; 2018 Jun; 50():11-18. PubMed ID: 29544728
[TBL] [Abstract][Full Text] [Related]
25. Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation.
Kuo CH; Yang SN; Tsai YG; Hsieh CC; Liao WT; Chen LC; Lee MS; Kuo HF; Lin CH; Hung CH
Pulm Pharmacol Ther; 2018 Feb; 48():37-45. PubMed ID: 28987803
[TBL] [Abstract][Full Text] [Related]
26. α and β catalytic subunits of cAMP-dependent protein kinase regulate formoterol-induced inflammatory gene expression changes in human bronchial epithelial cells.
Hamed O; Joshi R; Mostafa MM; Giembycz MA
Br J Pharmacol; 2022 Sep; 179(18):4593-4614. PubMed ID: 35735057
[TBL] [Abstract][Full Text] [Related]
27. Bioequivalence of budesonide plus formoterol (BF) Spiromax® and BF Turbohaler® (with and without charcoal block) in healthy volunteers.
Weisfeld L; Shu Y; Shah TP
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):593-602. PubMed ID: 26042485
[TBL] [Abstract][Full Text] [Related]
28. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.
D'Urzo AD; Rennard SI; Kerwin EM; Mergel V; Leselbaum AR; Caracta CF;
Respir Res; 2014 Oct; 15(1):123. PubMed ID: 25756831
[TBL] [Abstract][Full Text] [Related]
30. Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.
D'Urzo T; Donohue JF; Price D; Miravitlles M; Kerwin E
Expert Rev Respir Med; 2015 Oct; 9(5):519-32. PubMed ID: 26366803
[TBL] [Abstract][Full Text] [Related]
31. Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside.
Cazzola M; Calzetta L; Ora J; Puxeddu E; Rogliani P; Matera MG
Respir Med; 2015 Oct; 109(10):1305-11. PubMed ID: 26303336
[TBL] [Abstract][Full Text] [Related]
32. Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human.
Zhang M; Fawcett JP; Shaw JP
Br J Clin Pharmacol; 2002 Sep; 54(3):246-50. PubMed ID: 12236843
[TBL] [Abstract][Full Text] [Related]
33. Beta-2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1.
Salomon JJ; Hagos Y; Petzke S; Kühne A; Gausterer JC; Hosoya K; Ehrhardt C
Mol Pharm; 2015 Aug; 12(8):2633-41. PubMed ID: 25751092
[TBL] [Abstract][Full Text] [Related]
34. Time-to-treatment window and cross-sex potential of β
Scholpa NE; Simmons EC; Crossman JD; Schnellmann RG
Toxicol Appl Pharmacol; 2021 Jan; 411():115366. PubMed ID: 33316273
[TBL] [Abstract][Full Text] [Related]
35. Role of arformoterol in the management of COPD.
King P
Int J Chron Obstruct Pulmon Dis; 2008; 3(3):385-91. PubMed ID: 18990965
[TBL] [Abstract][Full Text] [Related]
36. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
Beasley R; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Pavord ID; Williams M; Weatherall M;
N Engl J Med; 2019 May; 380(21):2020-2030. PubMed ID: 31112386
[TBL] [Abstract][Full Text] [Related]
37. Formoterol treatment prevents the effects of endotoxin on muscle TNF/NF-kB, Akt/mTOR, and proteolytic pathways in a rat model. Role of IGF-I and miRNA 29b.
Martín AI; Gómez-SanMiguel AB; Priego T; López-Calderón A
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E705-E714. PubMed ID: 29969314
[TBL] [Abstract][Full Text] [Related]
38. Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size.
Hagg A; Colgan TD; Thomson RE; Qian H; Lynch GS; Gregorevic P
Sci Rep; 2016 Mar; 6():23042. PubMed ID: 26972746
[TBL] [Abstract][Full Text] [Related]
39. β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling.
Ngala RA; O'Dowd JF; Stocker CJ; Cawthorne MA; Arch JR
Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):761-73. PubMed ID: 23564017
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
